0920-0879 In-Person Interview Guide - Local Data Manager/Epidemiol

Form Approved

OMB No. 0920-0879

Expiration Date 01/31/2021

Attachment G- EPP- In-Person Interview Guide Data Manager

CDC estimates the average public reporting burden for this collection of information as 40 minutes per response, including the time for reviewing instructions, searching existing data/information sources, gathering and maintaining the data/information needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing burden to CDC/ATSDR Information Collection Review Office, 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; ATTN: PRA (0920-0879).

Instructions to Cloudburst Analyst: Read introduction, take notes, and ask permission to record interview.

Hello –

My name is __________ from The Cloudburst Group.

Thanks so much for taking the time to talk with me today. I am currently working with the Division of STD Prevention (or DSTDP) at CDC to assess the value, need, gaps, and impact of strategic partnerships between territorial and local health departments (LHD) with the highest STD morbidity (syphilis, chlamydia and gonorrhea) and their STD clinical partners. Today, I would like to ask you some questions about data related to the partnerships and any thoughts you had on working with the partners regarding the data.

As part of this assessment, we conducted an online assessment to find out more about STD clinical partnerships. As an extension of that assessment, you’ve been identified as someone who could help us learn more about the data collection and management aspects of partnerships. The findings will be used to inform LHD partnership building efforts to ensure effective strategies for achieving desired outcomes for priority STD clinical partnerships, and thereby, quality local STD services nationwide. Results of the in-depth assessments from these site visits in aggregate will be shared with other STD programs and CDC.

This interview will last no longer than 40 minutes. Your responses will be aggregated with the other interviews and all data will be shared in aggregate form. Is it ok if I record this interview just so that I can be sure to capture everything accurately?

Do you have any questions for me before we get started? [Record questions in transcript.]

Great, let’s begin.

(If there is an online assessment question and program response related to any of the data manager interview questions, the interviewer will preface each question by briefly summarizing the online assessment question and program response for contextual purposes)

Section 1: Background and Experience

I will start by asking you some questions about your background and experience.

1. How long have you been with this organization?

2. Could you please provide a brief description of your role in the organization?

Now I will ask you a few questions about data collection and management.

Section 2: Data Collection and Management

3. Please describe, briefly, the data collection and management procedures at your organization related to STD screening and treatment, new identification of cases.

4. How, if at all, has your organization’s ability to sustain STD data collection and management been affected by budget cuts?

5. In the online assessment, (state top three clinical partners from assessment) were identified as your program’s top 3 clinical partners. Would you agree that these are important? How do you relate to them? Can you describe any interactions you have with these partners?

6. [If answered sometimes or always to Q35 from online assessment] Can you tell me about the completeness of the STD positivity and treatment data you receive from your top three clinical partners?

7. Can you talk about how you worked with each of your top three clinical partners to get the data? [Ask this question for each partner they mentioned in the assessment.]

a. What type of data system changes, if any, have you or your three clinical partners made to ensure sharing of STD clinical outcome data?

The last section focuses on partners and data.

Section 3: Partners and Data

8. What partner-specific guidelines, procedures, or protocols have you put in place for data sharing with those three clinical partners?

a. With which partners, and what guidelines/procedures/protocols?

b. If there are none, what do you use to guide your efforts to share data?

9. What barriers or constraints do you have, if any, with data collection or extraction?

10. What data-related barriers or constraints do these top three clinical partners have?

11. How, if at all, do you work with your top three clinical partners on data analysis?

12. How, if at all, do you work with your top three clinical partners on using the data to inform program planning or implementation that involves the partnership?

Closing

13. This concludes the interview. Is there anything else that you would like to share that I missed, or any additional items that you would like to expand upon?

Thank you for taking the time to speak with me today. Your feedback will help CDC to better understand STD clinical partnerships. We will transcribe and analyze the results, which will be reported to CDC in aggregate. Do you have any questions about the next steps? I will now stop the recording.